Lawson gets $1.8B buyout offer

Lawson Software has received an unsolicited, non-binding proposal from Infor and Golden Gate Capital to acquire all of Lawson’s outstanding common stock at a price of $11.25 per share in cash, or approximately $1.8 billion. The parties are engaged in discussions regarding the proposal; however, there is no assurance that any agreement will be reached, according to a statement on the St. Paul, Minn.-based Lawson website.

Lawson’s board of directors has retained Barclays Capital as its financial advisor to assist in evaluating the proposal, as well as other possible strategic alternatives, according to the statement.

Lawson provides software, maintenance and consulting to industries including healthcare.

 

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.